The Authors analyzed the significance of BRAFV600E mutation in the primary tumor of PTC patients
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor.
VIOLA, DAVID;GIANNINI, RICCARDO;Ugolini, C.;BIAGINI, AGNESE;BASOLO, FULVIO;PINCHERA, ALDO;ELISEI, ROSSELLA
2010-01-01
Abstract
The Authors analyzed the significance of BRAFV600E mutation in the primary tumor of PTC patientsFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
